We are looking for an enthusiastic, highly motivated and creative
Investigative Pathologist in viral-based cancer therapies (f/m/diverse)
ViraTherapeutics is a subsidiary of the Boehringer Ingelheim (BI) group of companies: a perfect symbiosis of big pharma and a biotech start-up vibe. Located in the beautiful city of Innsbruck, Austria - a great place to live and to work - our dedicated Research team develops innovative viral-based immune-oncology treatment options.
We are looking for an enthusiastic, highly motivated and creative
Investigative Pathologist in viral-based cancer therapies (f/m/diverse)
In this science-focused position, you will be an integral driver of a translational science hub de-convoluting early anti-cancer research concepts.
Your role:
- Advance our histopathological expertise to develop human ex vivo based assays and investigate exploratory biomarkers associated with mechanisms of actions of oncolytic viruses/immunomodulatory therapeutics, in collaboration with the oncology translational science (OTS) group in BI discovery research
- Set-up and implement basic and new histopathological platforms to drive innovative science and drug discovery, including multiplex assays and digital pathology analyses
- Actively contribute to the design and pre-clinically validation of tissue-based biomarker assays and drive the development of capabilities of the pathology OTS group
- Interact and communicate within a highly dynamic external research network including partners from academia, industry and also the local clinical surgery departments (including presentations of the project work at scientific conferences)
- Train and supervise technical staff
Your ideal qualification:
- Certified pathologist (MD or DVM) with a profound expertise and scientific curiosity in human cancer etiology, with postdoctoral/clinical experience in cancer biology
- In depth knowledge and hands-on experience in basic and advanced tissue-based techniques such as routine histology, immunohistochemistry (IHC)/immunofluorescence (IF) (multiplexing), microscopy
- Experience in Digital Pathology is a strong asset
- Critical-thinking and trouble-shoot abilities to develop novel cell-based and molecular assays
- Sound knowledge of cancer immunology, cancer immunotherapy and human based ex vivo assays to foster translation of novel virus based anti-cancer therapeutics is preferred
- Excellent interpersonal and clear communication skills to integrate in a multi-disciplinary, lively and flexible team
- Evidence of scientific rigor and excellence as documented by first author peer-reviewed publications
- Fluency in English, both spoken and written; German language skills would be highly appreciated (otherwise willingness to learn German)
Our offer:
- You will have the unique possibility to drive research towards a novel cancer therapy at the interface of science and translation being part of an engaged scientific team.
- Work within the passionate, science-driven atmosphere of a small biotech company whilst at the same time benefit from being part of the global group of Boehringer Ingelheim, one of the pharmaceutical industry’s top 20 companies worldwide.
- We offer an attractive salary package in line with your qualification, experience and individual competencies.
Contact:
ViraTherapeutics GmbH, Dr. Monika Petersson, Bundesstrasse 27, 6063 Rum, Austria
www.viratherapeutics.com
We look forward to receiving your application by email: jobs@viratherapeutics.com